232 related articles for article (PubMed ID: 16229804)
1. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells.
Schwarze SR; Fu VX; Desotelle JA; Kenowski ML; Jarrard DF
Neoplasia; 2005 Sep; 7(9):816-23. PubMed ID: 16229804
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of the androgen independent prostate cancer cells demonstrates complex mechanisms mediating resistance to docetaxel.
Desarnaud F; Geck P; Parkin C; Carpinito G; Makarovskiy AN
Cancer Biol Ther; 2011 Jan; 11(2):204-12. PubMed ID: 21057205
[TBL] [Abstract][Full Text] [Related]
3. Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence.
Nagesh PKB; Chowdhury P; Hatami E; Kumari S; Kashyap VK; Tripathi MK; Wagh S; Meibohm B; Chauhan SC; Jaggi M; Yallapu MM
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38537-38554. PubMed ID: 31553876
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
5. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer.
Ramalho-Carvalho J; Graça I; Gomez A; Oliveira J; Henrique R; Esteller M; Jerónimo C
J Hematol Oncol; 2017 Feb; 10(1):43. PubMed ID: 28166834
[TBL] [Abstract][Full Text] [Related]
7. Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
Sapega O; Mikyšková R; Bieblová J; Mrázková B; Hodný Z; Reiniš M
Int J Oncol; 2018 Nov; 53(5):1997-2009. PubMed ID: 30226595
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway.
Shaikh IA; Brown I; Schofield AC; Wahle KW; Heys SD
Prostate; 2008 Nov; 68(15):1635-46. PubMed ID: 18668525
[TBL] [Abstract][Full Text] [Related]
9. siRNA-mediated silencing of Notch-1 enhances docetaxel induced mitotic arrest and apoptosis in prostate cancer cells.
Ye QF; Zhang YC; Peng XQ; Long Z; Ming YZ; He LY
Asian Pac J Cancer Prev; 2012; 13(6):2485-9. PubMed ID: 22938409
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent.
Chang BD; Swift ME; Shen M; Fang J; Broude EV; Roninson IB
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):389-94. PubMed ID: 11752408
[TBL] [Abstract][Full Text] [Related]
11. Tumor senescence as a determinant of drug response in vivo.
Roninson IB
Drug Resist Updat; 2002 Oct; 5(5):204-8. PubMed ID: 12450785
[TBL] [Abstract][Full Text] [Related]
12. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity.
Toso A; Revandkar A; Di Mitri D; Guccini I; Proietti M; Sarti M; Pinton S; Zhang J; Kalathur M; Civenni G; Jarrossay D; Montani E; Marini C; Garcia-Escudero R; Scanziani E; Grassi F; Pandolfi PP; Catapano CV; Alimonti A
Cell Rep; 2014 Oct; 9(1):75-89. PubMed ID: 25263564
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.
Ogura T; Tanaka Y; Tamaki H; Harada M
Int J Oncol; 2016 Jun; 48(6):2330-8. PubMed ID: 27082738
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
[TBL] [Abstract][Full Text] [Related]
15. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
Guccini I; Revandkar A; D'Ambrosio M; Colucci M; Pasquini E; Mosole S; Troiani M; Brina D; Sheibani-Tezerji R; Elia AR; Rinaldi A; Pernigoni N; Rüschoff JH; Dettwiler S; De Marzo AM; Antonarakis ES; Borrelli C; Moor AE; Garcia-Escudero R; Alajati A; Attanasio G; Losa M; Moch H; Wild P; Egger G; Alimonti A
Cancer Cell; 2021 Jan; 39(1):68-82.e9. PubMed ID: 33186519
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
[TBL] [Abstract][Full Text] [Related]
17. Malate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism.
Liu Q; Harvey CT; Geng H; Xue C; Chen V; Beer TM; Qian DZ
Prostate; 2013 Jul; 73(10):1028-37. PubMed ID: 23389923
[TBL] [Abstract][Full Text] [Related]
18. Blockade of γ-Glutamylcyclotransferase Enhances Docetaxel Growth Inhibition of Prostate Cancer Cells.
Takagi H; Ii H; Kageyama S; Hanada E; Taniguchi K; Yoshiya T; Chano T; Kawauchi A; Nakata S
Anticancer Res; 2019 Sep; 39(9):4811-4816. PubMed ID: 31519583
[TBL] [Abstract][Full Text] [Related]
19. KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone.
Mavridis K; Talieri M; Scorilas A
Biol Chem; 2010 Apr; 391(4):467-74. PubMed ID: 20128692
[TBL] [Abstract][Full Text] [Related]
20. DNA demethylation with 5-aza-2'-deoxycytidine induces the senescence-associated secretory phenotype in the immortal fish cell line, EPC.
Futami K; Maita M; Katagiri T
Gene; 2019 May; 697():194-200. PubMed ID: 30802536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
